Kyverna Therapeutics Inc. (KYTX)
KYTX trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$5.77
-7.08% on the day
Market cap
$356.8M
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | KYTX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001994702 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-04-02 |
| Latest annual report | 10-K | 2026-03-26 |
| Latest quarterly / interim | 10-Q | 2026-08-11 |
| Latest current report | 8-K | 2026-09-24 |
| Latest proxy | DEFA14A | 2026-04-13 |
Source: SEC EDGAR submissions feed, 186 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.8% |
| 1 month | -18.2% |
| 3 months | -23.5% |
| Year to date | -39.5% |
| 1 year | -17.9% |
| From 52-week high | -49.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| FENC | Fennec Pharmaceuticals Inc. | $10.18 | -5.04% | $356.6M |
| SCTX | Scribe Therapeutics Inc. | $19.12 | -7.50% | $362.0M |
| EIKN | Eikon Therapeutics Inc. | $6.72 | -7.44% | $364.0M |
| CCCC | C4 Therapeutics Inc. | $2.78 | -9.15% | $342.0M |
| TRXB | TRex Bio Inc. | $13.60 | -3.06% | $373.3M |
| EDIT | Editas Medicine Inc. | $2.44 | -11.09% | $375.5M |
| ZURA | Zura Bio Limited | $4.23 | +5.75% | $405.4M |
| AGEN | Agenus Inc. | $6.95 | -6.46% | $313.9M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier